Merck & Company (MRK) |
|
80.605 -0.445 (-0.55%)
|
08-07 15:03 |
|
Open: |
80.79 |
Pre. Close: |
81.05 |
|
High:
|
80.96 |
Low:
|
80.03 |
|
Volume:
|
4,181,589 |
Market Cap:
|
203,869M |
|
|
|
|
Merck & Co., Inc. provides healthcare solutions worldwide. It operates through Pharmaceutical and Animal Health segments. The company offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, chronic hepatitis C virus, HIV-1 infection, intra-abdominal, fungal infection, insomnia, and inflammatory diseases; neuromuscular blocking agents; cholesterol modifying medicines; and anti-bacterial and vaginal contraceptive products. It provides products to prevent chemotherapy-induced and post-operative nausea and vomiting; treat non-small-cell lung, ovarian and breast, esophageal, thyroid, cervical, and brain cancers; and prevent diseases caused by human papillomavirus, as well as vaccines for measles, mumps, rubella, varicella, shingles, rotavirus gastroenteritis, and pneumococcal diseases. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
82.565 - 83.062 |
83.062 - 83.431 |
|
Low:
|
79.395 - 80.053 |
80.053 - 80.542 |
|
Close:
|
80.188 - 81.157 |
81.157 - 81.877 |
|
Technical analysis |
as of: 2020-08-07 2:28:34 PM |
|
Overall:
|
  |
| Stoxline posted a STRONG SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 97.88 One year: 114.32 |
| Support: |
Support1: 79.00 Support2: 76.04 |
| Resistance: |
Resistance1: 83.80 Resistance2: 97.88 |
| Pivot: |
79.79  |
| Moving Average: |
MA(5): 81.48 MA(20): 79.56
MA(100): 78.25 MA(250): 82.40 |
| MACD: |
MACD(12,26): 0.80 Signal(9): 0.61 |
| Stochastic oscillator: |
%K(14,3): 63.46 %D(3): 69.14 |
| RSI: |
RSI(14): 54.83 |
| 52-week: |
High: 92.64 Low: 65.25 Change(%): -6.1 |
| Average Vol(K): |
3-Month: 956356 10-Days: 770855 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.MRK has closed below upper band by 37.6%. Bollinger Bands are 37.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Fri, 07 Aug 2020
Bayer, Merck Can't Be Pulled Back In Leg Amputation Suit - Law360
Fri, 07 Aug 2020
NIH to test remdesivir with Merck KGaA's interferon therapy as a COVID-19 treatment - MarketWatch
Fri, 07 Aug 2020
Merck snaps up Irish food traceability firm IdentiGEN - SecuringIndustry.com
Thu, 06 Aug 2020
Merck KGaA raises lower end of FY profit guidance range - Reuters UK
Wed, 05 Aug 2020
Merck enters agreement with Hanmi for investigational NASH drug - PMLiVE
Wed, 05 Aug 2020
Merck Animal Health Completes Acquisition of IdentiGEN - Business Wire
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: New York Stock Exchange |
| Sector: Healthcare |
| Industry: Drug ManufacturersGeneral |
| Shares Out. (M) |
2,520 |
| Shares Float (M) |
2,520 |
|
% Held by Insiders
|
0.08 |
|
% Held by Institutions
|
78.55 |
|
Shares Short (K)
|
14,880 |
|
Shares Short P. Month (K)
|
15,810 |
Stock Financials |
|
EPS
|
3.940 |
|
EPS Est This Year
|
3.870 |
|
EPS Est Next Year
|
4.160 |
|
Book Value (p.s.)
|
10.380 |
|
Profit Margin
|
21.10 |
|
Operating Margin
|
32.73 |
|
Return on Assets (ttm)
|
11.8 |
|
Return on Equity (ttm)
|
37.5 |
|
Qtrly Rev. Growth
|
11.5 |
|
Gross Profit (p.s.)
|
13.365 |
|
Sales Per Share
|
19.079 |
|
EBITDA (p.s.)
|
7.563 |
|
Qtrly Earnings Growth
|
10.40 |
|
Operating Cash Flow (M)
|
12,810 |
|
Levered Free Cash Flow (M)
|
9,000 |
Stock Valuations |
|
PE Ratio
|
20.43 |
|
PEG Ratio
|
1.63 |
|
Price to Book value
|
7.76 |
|
Price to Sales
|
4.22 |
|
Price to Cash Flow
|
15.84 |
Stock Dividends |
|
Dividend
|
2.260 |
|
Forward Dividend
|
2.440 |
|
Dividend Yield
|
0.03 |
|
Dividend Pay Date
|
2020-07-06 |
|
Ex-Dividend Date
|
2020-06-11 |
|
7 Binary Options
|
|
Your Ad Here
|
|
